Literature DB >> 15789379

Stenting vs. balloon angioplasty for discrete unoperated coarctation of the aorta in adolescents and adults.

Carlos A C Pedra1, Valmir F Fontes, Cesar A Esteves, Carlo B Pilla, Sérgio L N Braga, Simone R F Pedra, M Virginia T Santana, M Aparecida P Silva, Tarcisio Almeida, J Eduardo M R Sousa.   

Abstract

More information is needed to clarify whether stenting is superior to balloon angioplasty (BA) for unoperated coarctation of the aorta (CoA). From September 1997, 21 consecutive adolescents and adults (24 +/- 11 years) with discrete CoA underwent stenting (G1). The results were compared to those achieved by BA performed in historical group of 15 patients (18 +/- 10 years; P = 0.103; G2). After the procedure, systolic gradient reduction was higher (99% +/- 2% vs. 87% +/- 17%; P = 0.015), residual gradients lower (0.4 +/- 1.4 vs. 5.9 +/- 7.9 mm Hg; P = 0.019), gain at the CoA site higher (333% +/- 172% vs. 190% +/- 104%; P = 0.007), and CoA diameter larger (16.9 +/- 2.9 vs. 12.9 +/- 3.2 mm; P < 0.001) in G1. Aortic wall abnormalities were found in eight patients in G2 (53%) and in one in G1 (7%; P < 0.001). There was no major complication. Repeat catheterization (n = 33) and/or MRI (n = 2) was performed at a median follow-up of 1.0 year for G1 and 1.5 for G2 (P = 0.005). Gradient reduction persisted in both groups, although higher late gradients were seen in G2 (median of 0 mm Hg for G1 vs. 3 for G2; P = 0.014). CoA diameter showed no late loss in G1 and a late gain in G2 with a trend to being larger in G1 (16.7 +/- 2.9 vs. 14.6 +/- 3.9 mm; P = 0.075). Two patients required late stenting due to aneurysm formation or stent fracture in G1. Aortic wall abnormalities did not progress and one patient required redilation in G2. Blood pressure was similar in both groups at follow-up (126 +/- 12/81 +/- 11 for G1 vs. 120 +/- 15/80 +/- 10 mm Hg for G2; P = 0.149 and 0.975, respectively). Although satisfactory and similar clinical outcomes were observed with both techniques, stenting was a better means to relieve the stenosis and minimize the risk of developing immediate aortic wall abnormalities. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15789379     DOI: 10.1002/ccd.20311

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  14 in total

1.  Stenting in percutaneous treatment of adult aortic coarctation.

Authors:  R J Walhout; M C Post; H W M Plokker
Journal:  Neth Heart J       Date:  2012-08       Impact factor: 2.380

2.  Stenting of hypoplastic aortic segments with mild pressure gradients and arterial hypertension.

Authors:  D Boshoff; W Budts; L Mertens; B Eyskens; T Delhaas; B Meyns; W Daenen; M Gewillig
Journal:  Heart       Date:  2006-04-27       Impact factor: 5.994

Review 3.  Coarctation of the aorta.

Authors:  P Syamasundar Rao
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

4.  Esmolol-assisted balloon and stent angioplasty for aortic coarctation.

Authors:  Muthukumaran C Sivaprakasam; Gruschen R Veldtman; Anthony P Salmon; Richard Cope; Tom Pierce; Joseph J Vettukattil
Journal:  Pediatr Cardiol       Date:  2006-07-11       Impact factor: 1.655

5.  Serial assessment of arterial structure and function in patients with coarctation of the aorta undergoing stenting.

Authors:  Carlos A Jesus; Jorge E Assef; Simone R F F Pedra; Waldinai P Ferreira; Tathiane A Davoglio; Ana Cláudia G P Petisco; Mohamed H Saleh; David C S Le Bihan; Rodrigo B M Barretto; Carlos A C Pedra
Journal:  Int J Cardiovasc Imaging       Date:  2016-01-02       Impact factor: 2.357

6.  Endovascular management of coarctation of the aorta.

Authors:  D R Turner; P A Gaines
Journal:  Semin Intervent Radiol       Date:  2007-06       Impact factor: 1.513

Review 7.  The causes of Charcot-Marie-Tooth disease.

Authors:  P Young; U Suter
Journal:  Cell Mol Life Sci       Date:  2003-12       Impact factor: 9.261

Review 8.  [Catheter interventions for congenital heart disease].

Authors:  Thomas Krasemann
Journal:  Herz       Date:  2009-01-08       Impact factor: 1.443

9.  Multi-drug-resistant hypertension caused by severe aortic coarctation presenting in late adulthood.

Authors:  Stephanie M Meller; John T Fahey; John F Setaro; John K Forrest
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-02-03       Impact factor: 3.738

10.  Percutaneous treatment of native aortic coarctation in adults.

Authors:  P Luijendijk; S M Boekholdt; B J M Mulder; R J de Winter
Journal:  Neth Heart J       Date:  2012-08       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.